BioHarvest Sciences Inc.
CNVCF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $75 | $100 | $157 | $61 |
| - Cash | $5 | $2 | $4 | $2 |
| + Debt | $22 | $11 | $2 | $3 |
| Enterprise Value | $92 | $109 | $155 | $62 |
| Revenue | $13 | $5 | $2 | $0 |
| % Growth | 130.5% | 161.6% | 430.8% | – |
| Gross Profit | $6 | $1 | $1 | $0 |
| % Margin | 44.5% | 22.2% | 31.9% | 34.8% |
| EBITDA | -$10 | -$9 | -$9 | -$6 |
| % Margin | -77% | -166% | -410.7% | -1,458.1% |
| Net Income | -$13 | -$11 | -$10 | -$7 |
| % Margin | -99.1% | -204.4% | -467.5% | -1,662.6% |
| EPS Diluted | -0.93 | -0.86 | -0.79 | -0.68 |
| % Growth | -8.1% | -8.9% | -16.2% | – |
| Operating Cash Flow | -$9 | -$9 | -$7 | -$4 |
| Capital Expenditures | -$1 | -$1 | -$2 | -$0 |
| Free Cash Flow | -$10 | -$10 | -$8 | -$4 |